Literature DB >> 22673884

The Iranian model of living renal transplantation.

Mitra Mahdavi-Mazdeh1.   

Abstract

Organ shortage for transplantation remains a worldwide serious problem for kidney patients with end-stage renal failure, and several countries have tried different models to address this issue. Iran has 20 years of experience with one such model that involves the active role of the government and charity foundations. Patients with a desperate demand for a kidney have given rise to a black market of brokers and other forms of organ commercialism only accessible to those with sufficient financial resources. The current Iranian model has enabled most of the Iranian kidney transplant candidates, irrespective of socioeconomic class, to have access to kidney transplantation. The Iranian government has committed a large budget through funding hospital and staff at the Ministry of Health and Medical Education by supporting the brain death donation (BDD) program or redirecting part of the budget of living unrelated renal donation (LURD) to the BDD program. It has been shown that it did not prevent the development and progression of a BDD program. However, the LURD program is characterized by several controversial procedures (e.g., confrontation of donor and recipient at the end of the evaluation procedure along with some financial interactions) that should be ethically reviewed. Operational weaknesses such as the lack of a registration system and long-term follow-up of the donors are identified as the 'Achilles heel of the model'.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22673884     DOI: 10.1038/ki.2012.219

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  From blood donation to kidney sales: the gift relationship and transplant commercialism.

Authors:  Julian J Koplin
Journal:  Monash Bioeth Rev       Date:  2015 Jun-Sep

Review 2.  Kidney care in Haiti--the role of partnerships.

Authors:  Brian D Remillard; Jean H Buteau; Philip Cléophat
Journal:  Nat Rev Nephrol       Date:  2014-12-16       Impact factor: 28.314

3.  The ambiguous lessons of the Iranian model of paid living kidney donation : Fry-Revere, S. (2014). The kidney sellers: a journey of discovery in Iran. (Durham: Carolina Academic Press).

Authors:  Julian J Koplin
Journal:  Monash Bioeth Rev       Date:  2014 Sep-Dec

Review 4.  The present and future of transplant organ shortage: some potential remedies.

Authors:  Bahar Bastani
Journal:  J Nephrol       Date:  2019-08-09       Impact factor: 3.902

5.  Kidneys for Sale? A Commentary on Moeindarbari's and Feizi's Study on the Iranian Model.

Authors:  Frederike Ambagtsheer; Sean Columb; Meteb M AlBugami; Ninoslav Ivanovski
Journal:  Transpl Int       Date:  2022-06-24       Impact factor: 3.842

6.  Seventeen years' experience of peritoneal dialysis in Iran: first official report of the Iranian peritoneal dialysis registry.

Authors:  Iraj Najafi; Sudabeh Alatab; Shahnaz Atabak; Nader Nouri Majelan; Houshang Sanadgol; Khadijeh Makhdoomi; Mohammad Reza Ardalan; Jalal Azmandian; Abbas Shojaee; Amir Keshvari; Mostafa Hosseini
Journal:  Perit Dial Int       Date:  2013-06-03       Impact factor: 1.756

Review 7.  Regenerative Medicine in Organ and Tissue Transplantation: Shortly and Practically Achievable?

Authors:  A Heidary Rouchi; M Mahdavi-Mazdeh
Journal:  Int J Organ Transplant Med       Date:  2015-08-01

8.  The worsening transplant organ shortage in USA; desperate times demand innovative solutions.

Authors:  Bahar Bastani
Journal:  J Nephropathol       Date:  2015-10-01

9.  Hemodynamic factors affecting the suitability of the donated heart and kidney for transplantation.

Authors:  B Nozary Heshmati; F Ahmadi; P Azimi; N Tirgar; F Barzi; S M Gatmiri
Journal:  Int J Organ Transplant Med       Date:  2013

10.  Rate of family refusal of organ donation in dead-brain donors: the Iranian tissue bank experience.

Authors:  M Mahdavi-Mazdeh; A Khodadadi; N Tirgar; N Riazi
Journal:  Int J Organ Transplant Med       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.